Current Policy Challenges Impacting Biotechnology Innovation

Описание к видео Current Policy Challenges Impacting Biotechnology Innovation

At the Stanford Biodesign Policy Program's inaugural Health Technology Innovation Policy Conference, panelists discuss recent policy changes impacting investment and innovation in the biotechnology ecosystem and the implications for patient access.

Panelists:
• Jeff Allen, President & CEO, Friends of Cancer Research
• Ken Drazan, Chairman, CEO and Co-founder, ArsenalBio
• Emil Kakkis, President & CEO, Ultragenyx Pharmaceutical Inc.
• Peter Kolchinsky, Managing Partner, RA Capital Management
• Peter Marks, Director, Center for Biologics Evaluation and Research, US FDA

Moderator:
• Michael Ackermann, Director, Biotechnology, Stanford Biodesign

Комментарии

Информация по комментариям в разработке

Похожие видео